- Report
- August 2024
- 180 Pages
Global
From €1710EUR$1,920USD£1,492GBP
€2137EUR$2,400USD£1,865GBP
- Report
- May 2024
- 93 Pages
Global
From €1710EUR$1,920USD£1,492GBP
€2137EUR$2,400USD£1,865GBP
- Report
- October 2019
Global
From €1995EUR$2,240USD£1,741GBP
€2493EUR$2,800USD£2,176GBP
- Report
- June 2024
- 371 Pages
Global
From €4408EUR$4,950USD£3,847GBP
- Report
- December 2023
- 265 Pages
Global
From €4408EUR$4,950USD£3,847GBP
- Report
- September 2023
Global
From €4408EUR$4,950USD£3,847GBP
- Report
- May 2023
United States
From €1336EUR$1,500USD£1,166GBP
- Report
- November 2022
- 197 Pages
United States
From €3339EUR$3,750USD£2,915GBP
- Report
- November 2023
- 157 Pages
Global
From €2093EUR$2,350USD£1,826GBP
- Report
- May 2024
- 311 Pages
Global
From €2182EUR$2,450USD£1,904GBP
- Report
- September 2025
- 82 Pages
China
From €4141EUR$4,650USD£3,614GBP
- Report
- October 2024
- 122 Pages
Global
From €4141EUR$4,650USD£3,614GBP
- Report
- August 2024
- 111 Pages
Global
From €4141EUR$4,650USD£3,614GBP
- Report
- March 2024
- 145 Pages
Global
From €4141EUR$4,650USD£3,614GBP
- Report
- June 2023
- 155 Pages
Global
From €4141EUR$4,650USD£3,614GBP
- Report
- January 2023
- 131 Pages
Global
From €2226EUR$2,500USD£1,943GBP
- Report
- December 2021
- 353 Pages
Global
From €4898EUR$5,500USD£4,275GBP
- Report
- August 2023
- 336 Pages
Global
From €2449EUR$2,750USD£2,137GBP
€4898EUR$5,500USD£4,275GBP
- Report
- February 2024
- 77 Pages
Asia Pacific
From €2627EUR$2,950USD£2,293GBP
- Report
- January 2024
- 93 Pages
Europe
From €2627EUR$2,950USD£2,293GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more